Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

Patients with lung adenocarcinoma – the most common type of cancer among non-smokers -- carry a specific mutation in the ...

The partnership underscores Servier’s commitment to developing targeted therapies that address unmet medical needs in oncology; Servier will develop and commercialize BDTX-4933, ...

胰腺导管腺癌(pancreatic ductal ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) ...

Lung cancer is the leading cause of cancer deaths worldwide, mainly because it gets detected late. The discovery by the ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

EGFR 20 外显子插入（EGFR ex20ins）突变是非小细胞肺癌（NSCLC）中除 EGFR 19 外显子缺失（19-Del）和 21 外显子 L858R 点突变（21-L858R）两大常见突变外的 EGFR 第三大突变，占所有 NSCLC ...

近年来，随着分子肿瘤学的飞速发展，越来越多的研究揭示了遗传因素在肺癌发病机制中的重要作用。其中，表皮生长因子受体（Epidermal Growth Factor Receptor，EGFR）基因的突变成为了研究的热点。EGFR 突变不仅与 NSCLC 的发生发展密切相关，还影响着患者对靶向治疗 ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Biosciences announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease ...